drugset / Trial / NCT06555744

A Study of ZW191 in Participants With Solid Tumors

NCT06555744 ↗

Phase 1 Active not recruiting 145 enrolled Zymeworks BC Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if ZW191 is safe and can treat participants with advanced cancers, including ovarian, endometrial, and non-small cell lung cancers.

Timeline

Start
2024-10-30
Primary completion
2026-12
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ZW191 Other / unclassified — Intravenous

Indications